Domain-adaptive federated learning to develop machine learning models for predicting incident and progression of geographic atrophy
Project Number1R21EY035271-01A1
Former Number1R21EY035271-01
Contact PI/Project LeaderALAM, MINHAJ NUR
Awardee OrganizationUNIVERSITY OF NORTH CAROLINA CHARLOTTE
Description
Abstract Text
Abstract: Age-related macular degeneration (AMD) is one of the leading causes of severe vision loss. Early
detection, prompt intervention, and reliable assessment of treatment outcomes are essential to prevent
irreversible vision loss from advanced AMD stages such as geographic atrophy (GA). Patients at higher risk of
progression to GA would benefit from more frequent follow up visits, low vision referrals, and administration of
therapeutic interventions. Deep learning (DL) techniques have recently been applied to diagnose, classify, and
understand the progression trends of GA. However, a major limitation of DL is the need for large amounts of well
curated datasets from a diverse sub-population for robust diagnostic or prognostic performance. Due to the
overfitting on training data, the model tends to perform badly on external data (less generalizability of the model).
Moreover, efforts towards large public centralized datasets for DL research are hindered by significant barriers
to data sharing, privacy concerns, costs of image de-identification, and controls over how data would be used.
In this project, we aim to demonstrate the utility of novel federated DL approaches, which enable gaining insights
collaboratively, e.g., in the form of a consensus model, without moving patient data beyond the firewalls of the
institutions in which they reside. This novel paradigm of DL model training focuses on distributing the training of
DL models across institutions instead of sharing patient data and only the model parameters are shared with a
central server. We specifically seek to build robust risk models for predicting the occurrence and growth of GA.
Four data cohorts from the Stanford University, University of Illinois Chicago (UIC), Wake Forest University
(Wake Forest), and National Taiwan University (NTU) will be used to test the hypothesis that the prognostic
accuracy of the GA risk models using federated approach is more robust than models built on single institutional
datasets. Our first aim is to establish a federated learning (FL) framework for GA prediction utilizing longitudinal
multi-modal imaging and patient meta-data from four independent institutions (training and independent testing
dataset from Stanford, UIC, Wake Forest, and NTU). Key success criterion of the aim 1 study is to demonstrate
a robust and secure FL framework for GA risk model training within the multi-institutional environment. The
second aim is to integrate a novel adversarial domain alignment (ADA) technique into the FL framework to tackle
domain shift caused by heterogeneous data distribution at different institutions. To improve data representation
learning, and model transferability and generalizability across sub-population data, a novel self-supervised
contrastive learning (CL) based methods will be employed within the FL framework. Key success criterion of the
aim 2 study is to establish protocols for integrating domain alignment into FL framework and evaluate the FL-
trained GA prediction models deployed on new and previously unseen clinical data. Clinical deployment of such
AI prediction tools will facilitate identification of high-risk AMD patients as candidates for more frequent screening
and earlier treatment, leading to better clinical outcomes.
Public Health Relevance Statement
Public Health Relevance Statement
Advanced age-related macular degeneration (AMD) in the form of geographic atrophy
(GA) is a retinal disease that is a leading cause of severe vision loss worldwide. We are
developing artificial intelligence (AI) based techniques to collaboratively build GA risk
models using multi-institutional data cohorts with a diverse sub-population. Distributed
deep learning will be used to build robust models to improve clinical management of AMD.
No Sub Projects information available for 1R21EY035271-01A1
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 1R21EY035271-01A1
Patents
No Patents information available for 1R21EY035271-01A1
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 1R21EY035271-01A1
Clinical Studies
No Clinical Studies information available for 1R21EY035271-01A1
News and More
Related News Releases
No news release information available for 1R21EY035271-01A1
History
No Historical information available for 1R21EY035271-01A1
Similar Projects
No Similar Projects information available for 1R21EY035271-01A1